Top research execs from Teva, Allergan recruited to help lead Axovant out of the R&D wasteland

Roivant’s Vivek Ramaswamy may have run into a nasty mess with the failure of Axovant’s lead Alzheimer’s drug, but he can still recruit top talent for his growing organization.